The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a highly prevalent and lethal cancer worldwide; despite the curative treatment for HCC, the rate of tumor recurrence after hepatectomy remains high. Tumor recurrence can occur early (<2 years) or late (>2 years) as metastases or de novo tumors. Several tumor f...
Saved in:
| Main Authors: | Liang-He Yu, Nan Li, Shu-Qun Cheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | International Journal of Hepatology |
| Online Access: | http://dx.doi.org/10.4061/2011/416459 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comment on “Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis”
by: Han-Yue Mo, et al.
Published: (2016-01-01) -
Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma.
by: Kang Wang, et al.
Published: (2015-01-01) -
Evaluation of serum ESPL1 as a biomarker for early diagnosis of HBV-related hepatocellular carcinoma
by: Lu-Huai Feng, et al.
Published: (2025-04-01) -
Identifying key genes involved in HBV-related hepatocellular carcinoma: diagnose, prognosis, interaction and immune analysis
by: Yan Li, et al.
Published: (2025-08-01) -
Hepatocellular Carcinoma in Delta Hepatitis Versus HBV Monoinfection: Spot the Differences
by: Razvan Cerban, et al.
Published: (2025-05-01)